Ligand Reports Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Ligand Reports Third Quarter 2020 Financial Results

Ligand Pharma (LGND) Tops Q3 EPS by 6c, Offers FY20 and FY21 Guidance

October 30, 2020 8:07 AM EDT

Ligand Pharma (NASDAQ: LGND) reported Q3 EPS of $1.04, $0.06 better than the analyst estimate of $0.98. Revenue for the quarter came in at $41.8 million versus the consensus estimate of $44.36 million.

GUIDANCE:

Ligand Pharma sees FY2020 EPS of $3.95, versus the consensus of $3.91. Ligand... More